Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.440
-0.040 (-2.70%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Metagenomi Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 54 | 61 | 135 | - | - | - |
| Market Cap Growth | 5.01% | -54.98% | - | - | - | - |
| Enterprise Value | -66 | -82 | -93 | - | - | - |
| Last Close Price | 1.48 | 1.62 | 3.61 | - | - | - |
| PS Ratio | 2.14 | 2.41 | 2.58 | - | - | - |
| PB Ratio | 0.35 | 0.38 | 0.57 | - | - | - |
| P/TBV Ratio | 0.34 | 0.38 | 0.57 | - | - | - |
| Debt / Equity Ratio | 0.26 | 0.26 | 0.20 | 0.22 | 0.07 | 1.11 |
| Debt / FCF Ratio | - | - | - | - | 1.18 | 2.29 |
| Net Debt / Equity Ratio | -0.76 | -0.76 | -0.86 | -1.04 | -1.26 | -1.35 |
| Net Debt / EBITDA Ratio | 1.33 | 1.33 | 2.43 | 3.00 | 8.01 | 2.51 |
| Net Debt / FCF Ratio | 1.34 | 1.34 | 1.81 | 2.20 | -21.82 | -2.77 |
| Asset Turnover | 0.09 | 0.09 | 0.15 | 0.12 | 0.06 | - |
| Quick Ratio | 7.08 | 7.08 | 6.73 | 3.99 | 7.49 | 4.32 |
| Current Ratio | 7.22 | 7.22 | 6.91 | 4.04 | 7.56 | 4.33 |
| Return on Equity (ROE) | -44.66% | -44.66% | -34.69% | -28.04% | -27.62% | - |
| Return on Assets (ROA) | -21.99% | -21.99% | -16.12% | -12.59% | -10.03% | - |
| Return on Capital Employed (ROCE) | -48.40% | -48.40% | -30.90% | -26.50% | -12.20% | -20.50% |
| Earnings Yield | -162.76% | -144.46% | -57.78% | - | - | - |
| FCF Yield | -165.72% | -147.09% | -83.04% | - | - | - |
| Buyback Yield / Dilution | -12.79% | -12.79% | -870.10% | -0.15% | 40.27% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.